SONOMA PHARMACEUTICALS INC (SNOA) Stock Balance Sheet
NASDAQ:SNOA - Nasdaq - US83558L3033 - Common Stock - Currency: USD
| MRQ (2024-12-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.24M | 3.13M | 3.82M | 7.40M | 4.22M | |||
| Receivables | 2.40M | 5.99M | 6.42M | 4.78M | 4.66M | |||
| Inventories | 3.14M | 2.72M | 2.86M | 2.66M | 2.53M | |||
| Other Current Assets | 1.60M | 707.00K | 700.00K | 1.60M | 1.58M | |||
| Total Current Assets | 12.38M | 12.55M | 13.80M | 16.43M | 12.98M | |||
| Non-Current Assets | ||||||||
| PPE Net | 334.00K | 651.00K | 910.00K | 880.00K | 1.13M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 954.00K | 1.54M | 1.53M | 1.54M | 880.00K | |||
| Total Non-Current Assets | 1.29M | 2.19M | 2.43M | 2.42M | 2.01M | |||
| TOTAL ASSETS | 13.67M | 14.74M | 16.23M | 18.85M | 14.99M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 323.00K | 430.00K | 690.00K | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 120.00K | 600.00K | |||
| Accrued Expenses | 2.01M | 1.62M | 1.72M | 1.31M | 1.03M | |||
| Accounts Payable | 1.40M | 607.00K | 840.00K | 1.64M | 1.77M | |||
| Other Current Liabilities | 302.00K | 1.17M | 730.00K | 2.06M | 690.00K | |||
| Total Current Liabilities | 3.70M | 3.72M | 3.72M | 5.82M | 4.08M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 1.31M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 5.09M | 4.88M | 4.54M | 4.33M | 4.24M | |||
| Total Non-Current Liabilities | 5.09M | 4.88M | 4.53M | 4.33M | 5.54M | |||
| TOTAL LIABILITIES | 8.80M | 8.60M | 8.25M | 10.15M | 9.62M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -197.03M | -194.35M | -189.51M | -184.36M | -179.28M | |||
| Additional Paid In Capital | 206.45M | 203.21M | 200.90M | 197.37M | 189.22M | |||
| Common Shares | 160.00 | 2.00K | 10.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -4.55M | -2.72M | -3.42M | -4.31M | -4.58M | |||
| Shares Outstanding | 1.62M | 780.37K | 4.93M | 3.10M | 2.09M | |||
| Tangible Book Value per Share | 3.01 | 7.86 | 1.62 | 2.81 | 2.56 | |||
| Total Shareholders' Equity | 4.87M | 6.14M | 7.98M | 8.70M | 5.36M | |||
| TOTAL LIABILITIES AND EQUITY | 13.67M | 14.74M | 16.23M | 18.85M | 14.99M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.24 | |||
| Current Ratio | 3.34 | 3.37 | 3.71 | 2.82 | 3.18 | |||
| Return On Assets (ROA) | -27.42% | -32.80% | -31.73% | -27.00% | -26.35% | |||
| Return On Equity (ROE) | -76.96% | -78.78% | -64.54% | -58.51% | -73.69% | |||
All data in USD , ROIC based on taxRate of 0.21